真人做爰48姿势视图片|少妇真人直播免费视频|日本真人做爰A片|真人裸体做爰视频|真人与拘做爰视频免费观看|真人与拘做受免费视频一

透明質(zhì)酸氨基葡糖苷酶1(HYAL1)多克隆抗體

Polyclonal Antibody to Hyaluronoglucosaminidase 1 (HYAL1)

LUCA1; NAT6; Hyaluronidase-1; Lung carcinoma protein 1

  • 透明質(zhì)酸氨基葡糖苷酶1(HYAL1)多克隆抗體 產(chǎn)品包裝(模擬)
  • 透明質(zhì)酸氨基葡糖苷酶1(HYAL1)多克隆抗體 產(chǎn)品包裝(模擬)
  • 透明質(zhì)酸氨基葡糖苷酶1(HYAL1)多克隆抗體 DAB staining on IHC-P; Samples: Mouse Liver Tissue; Primary Ab: 10μg/ml Rabbit Anti-Mouse HYAL1 Antibody Second Ab: 2μg/mL?HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody (Catalog: SAA544Rb19)
  • 透明質(zhì)酸氨基葡糖苷酶1(HYAL1)多克隆抗體 DAB staining on IHC-P;
    Samples: Mouse Uterus Tissue
  • PAS092Mu01.jpg Figure. Western Blot; Sample: Recombinant HYAL1, Mouse.
  • 透明質(zhì)酸氨基葡糖苷酶1(HYAL1)多克隆抗體 Western Blot; Sample: Mouse Kidney lysate;
    Primary Ab: 2μg/ml Rabbit Anti-Mouse HYAL1 Antibody
    Second Ab: 0.2μg/mL?HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody
    (Catalog: SAA544Rb19)
  • 透明質(zhì)酸氨基葡糖苷酶1(HYAL1)多克隆抗體 Western Blot; Sample: Mouse Lung lysate;
    Primary Ab: 2μg/ml Rabbit Anti-Mouse HYAL1 Antibody
    Second Ab: 0.2μg/mL?HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody
    (Catalog: SAA544Rb19)
  • Certificate 通過ISO 9001、ISO 13485質(zhì)量體系認(rèn)證

特異性

該抗體是針對HYAL1的兔多克隆抗體。在免疫組織化學(xué)染色和免疫印跡實(shí)驗(yàn)中能識(shí)別HYAL1。

用法

Western blotting: 0.5-2μg/mL;
Immunohistochemistry: 5-20μg/mL;
Immunocytochemistry: 5-20μg/mL;
Optimal working dilutions must be determined by end user.

儲(chǔ)存

經(jīng)常使用則4°C保存。-20°C保存不超過兩年。避免反復(fù)凍融。

穩(wěn)定性

熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定,具體方法如下:在37°C孵育48小時(shí),沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi),在適當(dāng)?shù)臈l件下存儲(chǔ),損失率低于5%。

贈(zèng)品

相關(guān)產(chǎn)品

編號 適用物種:Mus musculus (Mouse,小鼠) 應(yīng)用(僅供研究使用,不用于臨床診斷!)
RPS092Mu01 透明質(zhì)酸氨基葡糖苷酶1(HYAL1)重組蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
PAS092Mu01 透明質(zhì)酸氨基葡糖苷酶1(HYAL1)多克隆抗體 WB; IHC; ICC; IP.

參考文獻(xiàn)

雜志 參考文獻(xiàn)
BMC Complementary and Alternative Medicine Identification of plasma protein markers common to patients with malignant tumour and Abnormal Savda in Uighur medicine: a prospective clinical study [Pubmed:25652121]
留言咨詢
兴和县| 伊通| 孟州市| 莒南县| 黔东| 峨眉山市| 赫章县| 城步| 汉中市| 卢氏县| 文山县| 游戏| 砀山县| 平度市| 岳池县| 新田县| 肇庆市| 兰州市| 阳泉市| 马鞍山市| 松阳县| 大邑县| 江阴市| 都安| 沁阳市| 静海县| 兴山县| 无极县| 建德市| 珠海市| 万源市| 高邑县| 武邑县| 普兰店市| 南投市| 张家口市| 兴文县| 谢通门县| 含山县| 三门县| 清苑县|